visilizumab
Showing 1 - 11 of 11
Immunotherapy, Refractory Leukemia, Relapsed Adult AML Trial in Suzhou (Visilizumab)
Recruiting
- Immunotherapy
- +3 more
- Visilizumab
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Dec 2, 2021
GVHD Trial in Tampa (Visilizumab, Tacrolimus, Methotrexate)
Terminated
- Graft Versus Host Disease
- Visilizumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jul 10, 2014
Ulcerative Colitis Trial in Worldwide (Visilizumab)
Terminated
- Ulcerative Colitis
- Visilizumab
-
Savannah, Georgia
- +15 more
Apr 26, 2012
Crohn's Disease Trial in Rochester (Visilizumab)
Completed
- Crohn's Disease
- Visilizumab
-
Rochester, MinnesotaMayo Clinic Rochester
Mar 6, 2012
Crohn's Disease Trial in Los Angeles, New York (Visilizumab)
Completed
- Crohn's Disease
- Visilizumab
-
Los Angeles, California
- +1 more
Mar 6, 2012
Ulcerative Colitis Trial in Worldwide (visilizumab)
Terminated
- Ulcerative Colitis
- visilizumab
-
Atlanta, Georgia
- +38 more
Mar 8, 2012
GVHD Trial in United States (Visilizumab)
Completed
- Graft vs Host Disease
- Visilizumab
-
Duarte, California
- +6 more
Mar 9, 2012
Severe Ulcerative Colitis Trial in United States (Visilizumab)
Completed
- Severe Ulcerative Colitis
- Visilizumab
-
Los Angeles, California
- +10 more
Mar 8, 2012
Ulcerative Colitis Trial in Worldwide (visilizumab)
Terminated
- Ulcerative Colitis
- visilizumab
-
Los Angeles, California
- +69 more
Mar 8, 2012
Ulcerative Colitis Trial in United States (Visilizumab)
Completed
- Ulcerative Colitis
- Visilizumab
-
Los Angeles, California
- +6 more
Mar 6, 2012
Graft-vs-Host Disease Trial in United States (Visilizumab)
Unknown status
- Graft-vs-Host Disease
- Visilizumab
-
Duarte, California
- +16 more
Jun 23, 2005